Comparison Chart NovoCure Limited

Stocks

NVCR

JE00BYSS4X48

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 23:00:00 27/10/2026 +03			5-day change	1st Jan Change
14.62 ^USD	+1.53%		-6.94%	+13.07%

10-01	Novocure Receives Approval In Japan For Optune Pax For The Treatment Of Unresectable Locally Advanced Pancreatic Cancer	CI
10-01	NovoCure's Optune Pax Approved in Japan for Advanced Pancreatic Cancer	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	NOVOCURE LIMITED	Medical Equipment	+1.53%	-6.94%	+13.07%	+7.66%	-86.80%	1.7B